(Q34464961)

2 August 2017

1 reference

title

C1 inhibitor: molecular and clinical aspects (English)

1 reference

2 August 2017

Marco Cicardi

1

1 reference

2 August 2017

Lorenza Zingale

2

1 reference

2 August 2017

Andrea Zanichelli

3

1 reference

2 August 2017

Emanuela Pappalardo

4

1 reference

2 August 2017

Benedetta Cicardi

5

1 reference

2 August 2017

publication date

11 November 2005

1 reference

Seminars in Immunopathology

2 August 2017

published in

1 reference

2 August 2017

volume

27

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

286-298

1 reference

C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

Proteolytic activities of two types of mannose-binding lectin-associated serine protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

Complement Regulatory Protein C1 Inhibitor Binds to Selectins and Interferes with Endothelial-Leukocyte Adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

A direct role for C1 inhibitor in regulation of leukocyte adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

Effect of C'1 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

Complement in ischemia reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

Lethal capillary leak syndrome after a single administration of interferon beta-1b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-005-0001-4

Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement

21 January 2018

1 reference

12 December 2020

The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant.

1 reference

12 December 2020

C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.

1 reference

12 December 2020

Beyond Mendel: an evolving view of human genetic disease transmission

1 reference

12 December 2020

Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate

1 reference

12 December 2020

Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion

1 reference

12 December 2020

Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization

1 reference

12 December 2020

Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations

1 reference

12 December 2020

Prekallikrein activation, C1 esterase inhibitor, and factor XII as predictors of adverse reaction to contrast media. A prospective study

1 reference

12 December 2020

Local bradykinin generation in hereditary angioedema

1 reference

12 December 2020

Molecular mousetraps and the serpinopathies

1 reference

12 December 2020

Rescue therapy with C1-esterase inhibitor concentrate after emergency coronary surgery for failed PTCA.

1 reference

12 December 2020

Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema.

1 reference

12 December 2020

Complement activation in relation to capillary leakage in children with septic shock and purpura

1 reference

12 December 2020

Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock

1 reference

12 December 2020

Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase.

1 reference

12 December 2020

How do we treat patients with hereditary angioedema

1 reference

12 December 2020

C1-inhibitor reduces the ischaemia-reperfusion injury of skeletal muscles in mice after aortic cross-clamping

1 reference

12 December 2020

Role of the P2 residue of complement 1 inhibitor (Ala443) in determination of target protease specificity: inhibition of complement and contact system proteases

1 reference

12 December 2020

In vitro interaction of C1-inhibitor with thrombin

1 reference

12 December 2020

C1-esterase inhibitor reduces infarct volume after cortical vein occlusion

1 reference

12 December 2020

Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate

1 reference

12 December 2020

Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema

1 reference

12 December 2020

C1 inhibitor potentiates the protective effect of organ preservation solution on endothelial cells during cold storage.

1 reference

12 December 2020

C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation

1 reference

12 December 2020

The regulation of human factor XIIa by plasma proteinase inhibitors

1 reference

12 December 2020

Activation of the early components of the classical complement pathway under physiologic conditions

1 reference

12 December 2020

Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia

1 reference

12 December 2020

Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia

1 reference

12 December 2020

Effects of choline-esterase inhibitor in experimental acute pancreatitis in rats. Preliminary results

1 reference

12 December 2020

Effects of C1-esterase inhibitor in three models of acute pancreatitis

1 reference

12 December 2020

Icatibant: HOE 140, JE 049, JE049

1 reference

12 December 2020

Local and remote ischemia-reperfusion injury is mitigated in mice overexpressing human C1 inhibitor

1 reference

12 December 2020

Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion

1 reference

12 December 2020

Proteases and protease inhibitors in taurocholate-induced acute pancreatitis in rats

1 reference

12 December 2020

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities

1 reference

12 December 2020

HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene.

1 reference

12 December 2020

Protective effect of C1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model

1 reference

12 December 2020

Plasma bradykinin in angio-oedema.

1 reference

12 December 2020

Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation

1 reference

12 December 2020

C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation

1 reference

12 December 2020

C1-esterase inhibitor reduces reperfusion injury after lung transplantation

1 reference

12 December 2020

The complement regulators C1 inhibitor and soluble complement receptor 1 attenuate acute lung injury in rabbits

1 reference

12 December 2020

The mechanism of Z alpha 1-antitrypsin accumulation in the liver

1 reference

12 December 2020

Conformational changes in serpins and the mechanism of alpha 1-antitrypsin deficiency

1 reference

12 December 2020

Partial purification of a serum inhibitor of C'1-esterase

1 reference

12 December 2020

In vivo study of the complement system during infusion of radiographic contrast media

1 reference

12 December 2020

Altered C1 inhibitor genes in type I hereditary angioedema

1 reference

12 December 2020

Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern

1 reference

12 December 2020

C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability

1 reference

12 December 2020

DX-88 and HAE: a developmental perspective

1 reference

12 December 2020

The pathophysiology of hereditary angioedema

1 reference

12 December 2020

Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11

1 reference

12 December 2020

Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice

1 reference

12 December 2020

C1-inhibitor concentrate for sepsis-related capillary leak syndrome

1 reference

12 December 2020

C1 inhibitor deficiency: consensus document

1 reference

12 December 2020

Complement and contrast material reactors

1 reference

12 December 2020

C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application

1 reference

12 December 2020

Radiographic contrast media and the coagulation and complement systems

1 reference

12 December 2020

C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction

1 reference

12 December 2020

Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema

1 reference

12 December 2020

Activity of C1 esterase inhibitor in patients with vascular leak syndrome after bone marrow transplantation

1 reference

12 December 2020

Sudden upper airway obstruction in patients with hereditary angioedema

1 reference

12 December 2020

Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin

1 reference

12 December 2020

In vivo microscopy reveals that complement inhibition by C1-esterase inhibitor reduces ischemia/reperfusion injury in the liver

1 reference

12 December 2020

Effects on peritoneal proteolysis and hemodynamics of prophylactic infusion with C1 inhibitor in experimental acute pancreatitis

1 reference

12 December 2020

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

1 reference

12 December 2020

The inhibitory properties of plasma against activated plasma thromboplastin antecedent (factor XIa) in hereditary angioneurotic edema

1 reference

12 December 2020

Complement 1 inhibitor is a regulator of the alternative complement pathway

1 reference

12 December 2020

Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization

1 reference

12 December 2020

Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement

1 reference

12 December 2020

Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury

1 reference

12 December 2020

Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients

1 reference

12 December 2020

Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarction

1 reference

12 December 2020

Apotransferrin, C1-esterase inhibitor, and alpha 1-acid glycoprotein for cerebral protection during experimental hypothermic circulatory arrest

1 reference

12 December 2020

Inactivation of kallikrein in human plasma

1 reference

12 December 2020

Functional analysis of the serpin domain of C1 inhibitor

1 reference

12 December 2020

Plasma protease inhibitor and anaphylatoxin inactivator levels in chronic urticaria/angioedema and in patients experiencing anaphylactoid reactions to radiographic contrast media

1 reference

12 December 2020

Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation

1 reference

12 December 2020

Serpinopathies and the conformational dementias

1 reference

12 December 2020

Level of plasma prekallikrein and its inhibitors in reactors and nonreactors during intravenous enhancement with contrast media

1 reference

12 December 2020

Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of “spontaneous” formation of bradykinin

1 reference

12 December 2020

Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma

1 reference

12 December 2020

Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.

1 reference

12 December 2020

Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma

1 reference

12 December 2020

C1 inhibitor prevents capillary leakage after thermal trauma

1 reference

12 December 2020

Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects

1 reference

12 December 2020

Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis

1 reference

12 December 2020

Plasma levels of prekallikrein, alpha-2-macroglobulin and C1-esterase inhibitor in patients with urticarial reaction to contrast media

1 reference

12 December 2020

Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily.

1 reference

12 December 2020

A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE.

1 reference

12 December 2020

Capillary leak syndrome in children who undergo cardiopulmonary bypass: clinical outcome in comparison with complement activation and C1 inhibitor.

1 reference

12 December 2020

Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy

1 reference

12 December 2020

Cyclical edema and shock due to increased capillary permeability

1 reference

12 December 2020

The role of the complement system in ischemia-reperfusion injury

1 reference

12 December 2020

Mechanisms that regulate the function of the selectins and their ligands

1 reference

12 December 2020

Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema

1 reference

12 December 2020

C1-esterase inhibitor substitution in sepsis

1 reference

12 December 2020

Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor

1 reference

12 December 2020

Plasminogen activator in normal subjects after exercise and venous occlusion: t-PA circulates as complexes with C1-inhibitor and PAI-1

1 reference

12 December 2020

Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder

1 reference

12 December 2020

Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes

1 reference

12 December 2020

The pathogenesis of hereditary angioedema

1 reference

12 December 2020

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor

1 reference

12 December 2020

Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis

1 reference

12 December 2020

Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor

1 reference

12 December 2020

C1-esterase inhibitor and a novel peptide inhibitor improve contractile function in reperfused skeletal muscle

1 reference

12 December 2020

Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate

1 reference

12 December 2020

Conformational disease

1 reference

12 December 2020

Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver

1 reference

12 December 2020

Detection of active kallikrein in induced blister fluids of hereditary angioedema patients

1 reference

12 December 2020

Insight into the mechanism of serpin-proteinase inhibition from 2D [1H-15N] NMR studies of the 69 kDa alpha 1-proteinase inhibitor Pittsburgh-trypsin covalent complex

1 reference

12 December 2020

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

1 reference

12 December 2020

Assay of kallikrein inhibitors and levels of acetone-activated kallikrein in plasma specimens from reactors to dextran or to contrast media

1 reference

12 December 2020

10.1007/S00281-005-0001-4

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1035319817

0 references

1 reference